InvestorsHub Logo
Followers 167
Posts 35856
Boards Moderated 3
Alias Born 10/20/2019

Re: None

Friday, 05/06/2022 10:27:56 AM

Friday, May 06, 2022 10:27:56 AM

Post# of 58
$IXHL has cash on hand and no debt...a great opportunity here with clinical trials coming.

The loyalty options expired on April 22, 2022. A total of 67.3M new shares are to be issued, resulting in $A23.6M additional capital for the Company's clinical trial endeavours that are now significantly ramping up in 2022 and 2023. The Company's current cash balance is approximately A$40.0M and Incannex has no debt.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IXHL News